Support and information needs for patients with non-small cell lung cancer receiving concurrent chemo-radiotherapy treatment with curative intent: Findings from a qualitative study
Affiliation
The Christie NHS Foundation Trust, Wilmslow Road, Withington, Manchester, M20 4BX, UKIssue Date
2023
Metadata
Show full item recordAbstract
Purpose: Concurrent chemotherapy and radiotherapy treatment (CCRT) is used to treat locally advanced Non-Small Cell Lung Cancer (NSCLC) in patients with suitable fitness. CCRT is associated with significant toxicity and time spent receiving treatment. Our aim was to identify the support and information needs of patients, and where possible their informal caregivers (IC), at key points along the CCRT pathway. Methods: Participants were NSCLC patients who were either about to undergo, currently receiving or had finished CCRT. Semi-structured interviews were conducted with participants, and their IC where applicable, at the treatment centre or participants' home. Interviews were audio recorded and transcribed prior to undergoing thematic analysis. Results: Fifteen patients were interviewed; five were interviewed with their IC. Themes of physical, psychological, and practical support needs are identified with associated subthemes exploring specific needs, such as dealing with late treatment effects, and how patients seek support. Information needs prior to, during and following CCRT were also established as predominant themes with subthemes detailing the needs at these time points. Examples include differences in participant desire for toxicity information and life after treatment. Conclusions: The need for disease, treatment and symptom related information and support remains consistent throughout CCRT and beyond. Further information and support for other matters including engaging in regular activities may also be desired. Time allocated within consultations to establish changes in needs or desire for further information may benefit patient and IC experience and QOL.Citation
Punnett G, Fenemore J, Blackhall F, Yorke J. Support and information needs for patients with non-small cell lung cancer receiving concurrent chemo-radiotherapy treatment with curative intent: Findings from a qualitative study. European journal of oncology nursing : the official journal of European Oncology Nursing Society. 2023 Mar 12;64:102325. PubMed PMID: 37146348. Epub 2023/05/05. eng.Journal
European Journal of Oncology NursingDOI
10.1016/j.ejon.2023.102325PubMed ID
37146348Additional Links
https://dx.doi.org/10.1016/j.ejon.2023.102325Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.ejon.2023.102325
Scopus Count
Collections
Related articles
- The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.
- Authors: Dieleman E, van der Woude L, van Os R, van Bockel L, Coremans I, van Es C, De Jaeger K, Knol HP, Kolff W, Koppe F, Pomp J, Reymen B, Schinagl D, Spoelstra F, Tissing-Tan C, van der Voort van Zyp N, van der Wel A, Wijsman R, Dielwart M, Wiegman E, Damhuis R, Belderbos J
- Issue date: 2023 Mar
- Concurrent versus sequential chemoradiotherapy for unresectable locally advanced stage III non-small cell lung cancer: Retrospective analysis in a single United Kingdom cancer centre.
- Authors: Spencer A, Williams J, Samuel R, Boon IS, Clarke K, Jain P
- Issue date: 2021
- Radical radiotherapy or chemoradiotherapy for inoperable, locally advanced, non-small cell lung cancer: Analysis of patient profile, treatment approaches, and outcomes for 213 patients at a tertiary cancer center.
- Authors: Shrimali RK, Nallathambi C, Saha A, Das A, Prasath S, Mahata A, Arun B, Mallick I, Achari R, Dabkara D, Thambudorai R, Chatterjee S
- Issue date: 2018 Apr-Jun
- Five-year survival rate analysis: the combination of fortnightly-administration of endostar and concurrent chemoradiotherapy versus concurrent chemoradiotherapy in the treatment of inoperable locally advanced non-small cell lung cancer.
- Authors: Ma H, Peng F, Xu Y, Bao Y, Hu X, Wang J, Fang M, Kong Y, Dong B, Chen M
- Issue date: 2021 Jul
- Comparison of the Efficacy and Toxicity of Concurrent Chemoradiotherapy and Durvalumab and Concurrent Chemoradiotherapy Alone for Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Metastasis.
- Authors: Abe T, Iino M, Saito S, Aoshika T, Ryuno Y, Ohta T, Igari M, Hirai R, Kumazaki YU, Miura YU, Kaira K, Kagamu H, Noda SE, Kato S
- Issue date: 2023 Feb